DSA 6: Chronic hepatitis, Chronic liver disease, Cirrhosis Flashcards
what is the etiology of chronic hepatitis?
how does it present?
group of d/o’s chronic inflam rxn in the liver for at least 6 months
common sxs: fatigue, malaise, anorexia, low-grade fever, jaundice
some pts - complication of cirrhosis
HBV: polyarteritis nodosa
HCV: mixed cryoglobulinemia
what is diagnositic for chronic hepatitis
CBC (platelets), chem panel, coag studies
Bx: historic classification - grade-necrosis/inflam & stage- degree of fibrosis
identify presence/absence of fibrosis (cirrhosis) : serum fibrosure &/or US elastography
what is the etiology of chronic HBV
endemic: Asia & sub-saharan Africa (90% vertical transmission)
Asymp healthy carrier stat - 75% Asia & Pacific rim
younger the age of infection - higher the probablity of chronicity
Risk HCC & cirrhosis: M>F
What increases/decreases progression of HCV?
increase: Male, drink > 50g EtOH daily, acquire infection after 40 yo, immunocompromised, tobacco/cannibis/fatty liver promote fibrosis
high risk of cirrhosis & HCC in genotype 1b
decrease: coffee
HCV Ab + HCV RNA = chronic
most HCV is curable
normal AST/ALT
what is the presentation and PE of AIH
type 1 (MC): Anti-Sm M &/or ANA (F, 30-50)
type 2: anti-LKM Ab
progessive jaundice, epistaxis, amenorrhea
healthy young woman w/ stigmata of cirrhosis - multiple spider telangiectasias, cutaneous striae, acne, hirsutism and hepatomegaly
extrahepatic: AI sxs, UC
what is diagnostic of AIH
AST/ALT may be > 1000
increased total bili
serology:
type 1: hypergammaglobulinemia, SMA, ANA
type 2: anti-LKM Ab
what is Tx for AIH
glucocorticoids
indicated for sxs dz: Bx shows bridging necrosis, 5-10x AST/ALT, hypergammaglobuliemia
what are complications of AIH
leads to cirrhosis –> HCC
what is the etiology of alc liver dz (SAAD > 1.1)
excessive: >80g/day in males & 30-40g/day in females x 10 yrs
(often deny Hx of excess alc use)
fatty liver (steatosis) : asymp- hepatomegaly & mild elevation in biochem livers (reverse if stop EtOH)
what is the clinical presentation of alcohol liver dz
asymp –> severe dz w/ jaundice, ascites, GI bleeds and encephalopathy
anorexia, N/V, fever, jaundice, tender hepatomegaly & RUQ pain
what lab are diagnostic of alcoholic liver dz (SAAG > 1.1)
chem (CMP) - AST 2x > ALT; Bili >=10 mg/dL
CBC: leukocytosis (severe) and leukopenia (sometimes and resolve after drinking), anemia (macrocytic/megaloblastic); thrombocytopenia
PT/PTT/INR: marked prolongation of PT
what imaging diagnostics are found in alcohol liver dz
imaging: US- exclude biliary obstruction; CT w/ IV contrast/MRI: collateral vessels, space-occupying lesions; US elastography: fibrosis
liver Bx: mallory-denk bodies
what is the treatment for alcoholic liver dz
abstinence from alcohol
daily multivitamin, thiamine 100 mg, folic acid 1 mg, zinc: glucose administration increase thiamine requirement & can cause wernicke-korsakoff syndrome if thiamine not co-administered
severe alcoholic hepatitis = steroids, pentoxifylline
liver transplant - abstain from alc for 6 months
what is the prognosis and complications of alcoholic liver dz (SAAG >1.1)
MC precursor to cirrhosis in US –> risk of HCC
wernicke-encephalopathy- treat w/ thiamine
korsakoff (permanent)
adverse prognostic factors: poor prognosis -ascities, variceal hemorrhage, encephalopathy, hepatorenal syndrome. critically ill pt w/ alc hepatitis have 30 day mortality rate >50%
what is labs/symptoms present in severe alcoholic hepatitis
total bili > 8-10 and PTT > 6 = (50% mortality/susceptible to infxn, including invasive aspergilosis)
hypoalbuminemia, azotemia
what is
Maddrey’s discriminant fxn (DF)
Glasgow alc hepatitis score
A model for End-stage liver dz
Maddrey’s discriminant fxn (DF): >=32 - poor prognosis; may benefit from steroids
Glasgow alc hepatitis score: predict mortality based on multivariable model; >= 9 -higher survival rates
A model for End-stage liver dz: >21 significant mortality in alc hepatitis
what is hepatic steatosis and what is the etiology
fatty liver –> fatty liver that causes liver inflam = steatohepatitis –> cirrhosis
etiology: alc related or non-alc fatty liver dz (NAFLD) - < 20 g/day F and <30 g/day M
wha tis the etiology of NAFLD
MCC of chronic liver dz in USA
principal causes & increased risk for NAFLD - metabolic syndrome (obesity, DM, hypertriglyderigemia) - increased risk for CV disease, CKD, colorectal CA
protective: physical activity & coffee consumption
cirrhosis caused by NASH is UNCOMMON in african americans
what is the presentation and PE of NAFLD
what is the complication
asymp or mild RUQ
hepatomeg
complication - cirrhosis
what is diagnositic of NAFLD
labs: mild increase AST/ALT and ALP - may be normal =< 80% hepatic steatosis
imaging - US elastography- assess liver stiffness can be used to ESTIMATE hepatic fibrosis
Liver Bx = Diagnostic - histologic- local infiltration by PMN and mallory hylaine,indistinguishale from alc hepatitis, =NASH
what is the treatment/management of NAFLD
lifestyle modifications- wt loss, dietary fat restriction, exercise, vit E, gastric bypass
statins NOT contraindicated
in advanced cirrhosis –> liver transplant
What is the etiology of a1-antitrypsin def
AR
low level of a1-antitrypsin def –> build up in hepatocytes –> liver damage & decrease protease inhibitors
pulmonary emphysema
panacinar emphysema (at young age) - lower lobes; **smokers –> COPD/emphysema of upper lobe
liver dz
MC diagnosed inherited hepatic disorder in infants & children
what is diagnostic of a1-antitrypsin def
low a1-antitrypsin def level
check a1-antitrypsin def phenotype
PIZZ - homozygous (reduction in enzyme)
what are treatments of a1-antitrypsin def?
if not treated, what are complications?
smoking abstinence/cessation
liver transplant - MC genetic cause requiring liver transplant in kids
complication - emphysema at young age; cirrhosis –> HCC
what is the etiology of PBC
progressive non-suppurative destructive intrahepatic cholangitis
infxn w/ Novosphingobium aromaticivorans or chlymagophilia -may trigger/cause it
= AI destruction of small intrahepatic bile ducts/cholestasis
Female, median = 50 yo
asymp isolated elevation of ALP or impaired bile excretion
what are the RF and clinical manifestation of PBC
RF: UTI, smoking, use of hormone replacement therapy, hair dye
clinical manifestation: pruritus, progressive jaundice, xanthelasma, osteoporsis, HSM, portal HTN
associated w/ AI d/o’s